Showing results (281-290 of 385) with videos related to
Sort By:
Pageof 39
Multiple Sclerosis and Related Disorders|June 30, 2026
Real-world analytical and clinical evaluation of the Siemens Atellica® immunoassay for plasma neurofilament light chain in multiple sclerosisValerio Nicolella, Carmela Polito, Vincenzo Criscuolo, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2021
Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx studyBrian M Sandroff, Robert W Motl, Maria Pia Amato, et al.Journal of Neurology|August 27, 2024
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA)Clara Grazia Chisari, Maria Pia Amato, Alessia Di Sapio, et al.European Journal of Neurology|October 30, 2024
Association between CD20+ T lymphocytes and neuropsychological findings in multiple sclerosisAntonio Esposito, Fabrizia Falco, Giulia Scalia, et al.Multiple Sclerosis and Related Disorders|November 7, 2025
Anti-EBV antibody reduction during ocrelizumab treatment is not associated with multiple sclerosis outcomesAntonio Esposito, Luca Corsaro, Ilaria Delle Cave, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2025
Dysarthria assessment in multiple sclerosis patientsDavide Ranucci, Fabrizia Falco, Valerio Nicolella, et al.Toxins|November 10, 2022
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple SclerosisFederica Novarella, Antonio Carotenuto, Paolo Cipullo, et al.Multiple Sclerosis and Related Disorders|April 29, 2022
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosisEmanuela Zappulo, Antonio Riccardo Buonomo, Marcello Moccia, et al.Neurorehabilitation and Neural Repair|May 4, 2025
Correlates of Processing Speed Change With Combined Cognitive Rehabilitation and Exercise in Progressive MS: Secondary Analysis of the CogEx TrialBrian M Sandroff, Robert W Motl, Roberto S Hernandez, et al.AJNR. American Journal of Neuroradiology|July 3, 2025
Predicting Ten-Year Clinical Outcomes in Multiple Sclerosis with Radiomics-Based Machine Learning ModelsMario Tranfa, Maria Petracca, Renato Cuocolo, et al.Pageof 39